“SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024020, Feb. 2024, doi: 10.4084/MJHID.2024.020.